Physio-Control, Inc., a global leader in emergency medical solutions and wholly‐owned subsidiary of Medtronic, Inc. (NYSE: MDT), today announced availability of new solutions for the LIFEPAK® 15 monitor/defibrillator designed to help hospital, as well as pre-hospital, teams provide more effective patient care. The 15, when used together with CODE-STAT™ data review software and the LIFENET® System data network, empowers hospital and pre-hospital care teams with a powerful new suite of tools that utilize patient, performance and device data to improve care, trim operational costs and streamline equipment management.
The new solutions strengthen the 15’s position as the most clinically- and operationally-advanced monitor/defibrillator available for emergency medical teams, and include:
“The LIFEPAK 15 monitor was designed as a platform that allows for continuous innovation. These hospital solutions for the 15 add new clinical capabilities, providing clinicians with the broadest selection of monitoring options available,” said Brian Webster, president, Physio-Control, Inc. “With therapeutic hypothermia treatment for cardiac arrest patients already commonplace in hospitals and increasing in EMS use, we expect the new continuous temperature monitoring to be adopted rapidly by customers.”
Physio-Control continues to build on a 56-year heritage of providing innovative, reliable equipment to lifesaving teams around the world. As an upgradeable platform, the 15 can adapt to evolving protocols and new guidelines as customers prepare to deliver new capabilities. The 15 provides the widest range of energy dosing up to 360 joules, CPR Metronome for guiding chest compressions and the broadest selection of monitoring options available, including non-invasive continuous EtCO2 monitoring and monitoring of carbon monoxide, SpO2 and methemoglobin offered by Masimo®.
For current LIFEPAK customers, the 15 reduces transition costs, with a user interface that complements the market-leading LIFEPAK 12 defibrillator/monitor. Emergency care providers are able to work with a mixed fleet of LIFEPAK monitors, and transition their equipment when budgets allow—enabling them to save on critical operational costs and minimize their overall training resources.
About Physio-Control, Inc.
Physio-Control, a wholly-owned subsidiary of Medtronic, Inc., is located in Redmond, Wash. Physio-Control pioneered defibrillation technology more than 56 years ago. The company is the world’s leading provider of external defibrillation and monitoring technology for the treatment of sudden cardiac arrest and other cardiorespiratory emergencies. To find out more about Physio-Control, go to www.physio-control.com or call 1-800-442-1142.
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.